Rohypnol â contâd. Rohypnol Overview RohypnolÂ® is a trade name for flunitrazepam, a central nervous system (CNS) depressant that belongs to a class of drugs known as benzodiazepines. Flunitrazepam is also marketed as generic preparations and other trade name products outside of the United States.
(May 2013). An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.
Physician reviewers determined (1) whether an adverse event occurred, (2) whether the event was on the NQF list of Serious Reportable Events. or the Medicare list of hospital-acquired conditions (HAC), (3) what the. level of harm was to the patient, and (4) whether the event was. preventable.